The Florida Society of Nephrology would like to express our heartfelt gratitude to all the sponsors and exhibitors who generously support the FSN 57th Annual Meeting. Attendees will have the opportunity to learn more about these organizations and meet their representatives at the meeting.
|
Platinum Sponsor | | |
| Aurinia is a biopharmaceutical company focused on developing therapies for patient populations impacted by serious diseases with a high unmet medical need. Please visit www.AuriniaLN.com to learn more. | |  |
| | | |
| Horizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook. | |  |
| | | |
| At Travere Therapeutics, we are in rare for life. We come together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent — that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope — today and tomorrow. | |  |
| | | |
Gold Sponsor | | |
| Alnylam | |  |
| AstraZeneca | |  |
| | | |
| Silver Sponsors | | |
| | | |
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing aging population. Bayer is committed to the principles of sustaining development, and the Bayer brand stands for trust, reliability, and quality throughout the world.
| |  |
| | | |
| Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. The company's Specialty Brands reportable segment's areas of focus include autoimmune and rare diseases. Its Specialty Generics reportable segment includes specialty generic drugs and active pharmaceutical ingredients. To learn more about Mallinckrodt, visit www.mallinckrodt.com. | |  |
| | | |
| Medical Protective | |  |
| | | |
| Novartis is reimagining medicine to improve and extend people’s lives. As leading global medicines company, we focus on five core attractive therapeutic areas and key technology platforms to alleviate some of society’s greatest disease burdens. Ranking among the world’s top companies investing in R&D, our products reach 280 million people globally. | |  |
| | | |
| Risk Strategies/Danna Gracey | |  |
| | | |
Bronze Sponsors | | |
| Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. For more information, please visit www.alexion.com. | |  |
| | | |
| Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. | |  |
| | | |
| Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. | |  |
| | | |
| Calliditas is dedicated to expanding treatment options and establishing new standards of care for people with rare diseases. By drawing on our expertise in pharmaceutical product development and leveraging our strategic partnerships, we quickly and efficiently identify, develop, and market a pipeline of innovative medicines that can improve the lives of patients. | |  |
| | | |
CorMedix, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions. | |  |
| | | |
Elixia is a tech-enabled clinical site organization specializing in Cardiology, Nephrology, Behavioral Health and Infectious disease trials.
Elixia’s mission: To provide pharmaceutical companies with a breakthrough approach to clinical trials while empowering physician research, reinventing access to diverse populations, and accelerating the collection of data vital to high-quality clinical research outcomes while comprehensively supporting the drug development process. | |  |
| | | |
| Empower HCP is a full-service healthcare compliance and networking firm specializing in comprehensive compliance solutions for healthcare providers and systems. Compliance is the glue that holds the healthcare industry together and ensures that patients receive high-quality care in a safe and ethical environment. Our mission is to empower our clients with the tools, resources, and knowledge they need to navigate the complex regulatory landscape. | |  |
| | | |
| Eurofins Transplant Genomics. Transplant Genomics aims to improve transplant outcomes through molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes, and enable optimization of therapy. | |  |
| | | |
| Fresenius Medical Care North America. With comprehensive solutions for people living with chronic kidney disease and related conditions, we are working together to improve the quality of life of every patient, every day. We are transforming healthcare through research, innovation, and compassion. | |  |
| |
|
| OPKO Renal Division focuses on developing proprietary products to treat secondary hyperparathyroidism associated with chronic kidney disease. OPKO’s expertise in Vitamin D biochemistry, metabolism and physiology, combined with its experience in successfully bringing Vitamin D therapeutics to market uniquely positions the Renal Division to improve the lives of CKD patients. | |  |
| | | |
Outset Medical. The Tablo Dialysis system is the first-of-its-kind, fully integrated system for Adaptive Dialysis. Tablo can treat patients across the care continuum and clinical spectrum, from 24-hour Extended Therapy (XT) in the ICU to home hemodialysis treatments all while reducing the cost and complexity associated with traditional dialysis programs.
| |  |
| | | |
| Class 1 Sponsors |
| |
| Ardelyx is a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. | |  |
| | | |
Arkana Laboratories is a center for esoteric pathology focused on one thing: improving care for patients. We are committed to providing doctors with the highest quality, clinicopathologic discussion possible.
We do this by providing world-class diagnostics for renal pathology. Biopsy reports are final (including EM) the same day the tissue arrives at our lab, supplying nephrologists with the needed data to begin treatment plans immediately. | |  |
| | | |
Central Florida Kidney Centers. Providing compassionate kidney care in Central Florida & Brevard for 50 years, Central Florida Kidney Centers, a non-profit organization, makes our patients well-being our top priority every day. We offer in-center, peritoneal, home hemodialysis and CKD Education delivered by caring, knowledgeable staff of physicians, nurses, dietitians, and social workers. | |  |
| | | |
Chiesi Global Rare Diseases is a business unit of the Chiesi Group, focused on research & development of treatments for rare and ultra-rare disorders. | |  |
| | | |
Fresenius Medical Care Renal Pharmaceuticals specializes
in the prescription needs of ESRD patients and is dedicated to providing
pharmaceuticals to more than 400,000 individuals undergoing dialysis throughout
the United States. Our renal pharmaceutical products include Velphoro® (sucroferric oxyhydroxide) chewable tablets, KORSUVA® (difelikefalin) injection, and Venofer® (iron
sucrose injection USP). | |  |
| | | |
| Healthmap Solutions is a Kidney Population Health Management company serving health plans, health systems, ACOs, and provider groups seeking value-based solutions for their chronic kidney disease and end-stage renal disease populations. Using advanced technology, predictive analytics, and clinical expertise, Healthmap improves clinical outcomes while lowering the total cost of care. | |  |
| | | |
| Kyowa Kirin strives to create and deliver novel medicines with life-changing value. As a Japan-based Global Specialty Pharmaceutical Company, we apply cutting-edge science and expertise in antibody research and engineering to address the needs of patients and society across multiple therapeutic areas, including Nephrology, Oncology, Immunology/Allergy and Neurology. Across four global regions – Japan, Asia Pacific, North America and EMEA/International – we are united by our shared values of commitment to life, teamwork, innovation and integrity, and a drive to advance innovations that have a profound impact on patients. You can learn more at: https://kkna.kyowakirin.com. | |  |
| | | |
| | |
| | | |
| Nephro-Tech, Inc. has proudly served the CKD community since 1992, providing high quality pharmaceuticals at affordable prices. Our range of products address the needs of both CKD and ESKD patients. Our newest product, RenaCarb, is for the management of metabolic acidosis in CKD. For more information or samples, please visit us at www.nephrotech.com | |  |
| | | |
N'Sync Consulting brings together a unique blend of expertise in the field of End Stage Renal Disease Management. Our principals bring over 100 years' experience in all aspects across the ESRD spectrum. N'Sync Consulting provides comprehensive consulting, management and dialysis billing services to the Renal Disease Industry.
| |  |
| | | |
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI).
| |  |
| | | |
| Tampa General Hospital Transplant Institute A national leader in transplant surgery for nearly 50 years, Tampa General Hospital Transplant Institute has performed more than 7,500 kidney transplants. Ranked in the top 10 in the nation by volume, the TGH Transplant Institute brings together a world-class team of specialists to offer individualized care for patients. | |  |
| | | |
University of Florida Health Pathology Laboratories is the largest academic outreach pathology laboratory in Florida, offering comprehensive pathology services to hospitals and physician groups throughout the state.
To learn more, visit us online at: pathlabs.ufl.edu.
| |  |
| | |
| Class 2 Sponsors | | |
Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of medicines for rare metabolic diseases. For any Medical Information inquiries, please email MedInfoUSA@amicusrx.com (US Only) and Medinfo@amicusrx.com (International). For any Patient Advocacy inquiries, please email patientadvocacyintl@amicusrx.com.
| |  |
| | | |
Azura Vascular Care operates and manages a national network of outpatient vascular care and ambulatory surgery centers that specialize in minimally invasive techniques to treat a wide range of vascular conditions in a comfortable outpatient setting.
| |  |
| | | |
| Neway LLC. Neway is your trusted dialysis lab partner. Neway with Quest Diagnostics® gives you next-day lab results, increasing the velocity and quality of patient care. The Neway Lab Stewardship Program® helps your dialysis organization eliminate waste, reducing your lab cost, while giving you global cost of care control. | |  |
| | | |
| Nuwellis Aquapheresis therapy, delivered by the Aquadex SmartFlow System, uses a simplified approach to ultrafiltration for the removal of salt and water in patients with Fluid Overload. Using the Aquadex SmartFlow, medical practitioners can specify and control the amount of fluid to be extracted in a safe, predictable, and effective manner. | |  |
| | | |
Pentec Health improves healthcare by solving and simplifying complex care challenges not addressed by other providers. Our unique solutions, based on empathy, technical expertise, and collaboration, deliver exceptional results through proven delivery models that honor patients’ and providers’ time and needs and improve outcomes through trusted, long-term relationships.
| |  |
| | | |
Physician Software Systems – technology to meet the challenges dialysis providers are facing in 2024! Providing AI-driven, individualized, ESA and iron dosing decision support to improve patient care and automation to streamline clinical tasks and improve efficiency; enabling operational oversight and assistance from senior team members to staff at individual units.
| |  |
| | | |
Veloxis Pharmaceuticals, Inc., an Asahi Kasei company, is a fully integrated specialty pharmaceutical company committed to improving the lives of transplant patients. Headquartered in Cary, North Carolina, USA, Veloxis is focused on the global development and commercialization of medications utilized by transplant patients and by patients with serious related diseases. For further information, please visit www.veloxis.com.
| |  |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Florida Women in Nephrology Chair
FSN President
Print Page